First Human Dose Trial of NNC0215-0384 in Subjects With Rheumatoid Arthritis

NCT01611688 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammation
Rheumatoid Arthritis

Interventions

DRUG: NNC0215-0384
DRUG: placebo
DRUG: NNC0215-0384

Sponsor

Novo Nordisk A/S